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 Abstract (200 words) 
 
Purpose of review:  The aim of this review is to summarise some of the key dietary interventions 
recommended for common GI disorders and discuss recent evidence regarding their nutritional 
implications.   
Recent findings:  Evidence from short-term randomised controlled trials of the low FODMAP diet in 
irritable bowel syndrome suggests intake of some nutrients such as fibre, iron and calcium may be 
compromised, although findings vary across studies, meanwhile long-term uncontrolled trials 
suggest dietary adequacy improves with reintroduction and personalisation. The gluten-free diet, 
which is the only treatment for coeliac disease although it is increasingly used for other perceived 
health benefits, has also been shown to negatively influence overall diet quality. Although high-fibre 
diets may be beneficial in diverticular disease and constipation, it may lead to reductions in energy 
intake and nutrient absorption in at-risk populations. 
Summary: The role of therapeutic diets in the management of gastrointestinal disorders is 
increasingly recognised, but there are limited studies investigating the nutritional implications of 
these. The judicious use of expertise in nutrition and dietetics should minimise potential nutritional 
deficits, however further prospective trials are needed to identify subgroups of individuals most 
susceptible to these deficits and the nutrients most at risk. 
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Introduction  
Dietary interventions play an integral role in the management of some gastrointestinal (GI) 
disorders. Whilst diet remains the mainstay of treatment for coeliac disease, there has been 
intensifying interest in the use of diet to manage GI disorders such as irritable bowel syndrome (IBS), 
constipation, diverticular disease and inflammatory bowel disease (IBD). There has not only been 
progressing momentum in the identification and/or evaluation of new dietary treatments for these 
disorders, but also much needed synthesis of findings in the form of systematic reviews and meta-
analyses. Exclusion of one or more foods or dietary constituents for the purposes of managing GI 
disorders may increase the risk of inadequate nutrient intake and may have other other nutritional 
implications. This review will summarise some of the key dietary interventions recommended for 
common GI disorders and discuss recent evidence regarding their nutritional implications.  
 
Low FODMAP diet 
Multiple randomised controlled trials (RCT) report that the low FODMAP diet leads to improvement 
in symptoms of irritable bowel syndrome (IBS), such as bloating and abdominal pain, in 50-80% of 
individuals (1, 2)*, although the quality of these trials with respect to their choice of control groups 
and blinding has been questioned (3). The low FODMAP diet has also been investigated in quiescent 
inflammatory bowel disease (IBD), demonstrating efficacy for symptoms such as diarrhoea and 
bloating  (4), although many trials are uncontrolled (Prince) and only one RCT has been published 
(Pedersen). The two major mechanisms by which FODMAP carbohydrates provoke GI symptoms are 
through increasing small intestinal water and colonic gas, which occur 60-120 minutes post ingestion 
(5)**. Other less studied mechanisms include the effect of FODMAP carbohdyrates on altering GI 
motility and modifying the microbiome (1)*1 
 
 
The low FODMAP diet involves the restriction of oligosaccharides (inulin-type fructans, galacto-
oligosaccharides) found in wheat and pulses, disaccharides (lactose) found in dairy products, 
monosaccharide (fructose in excess of glucose) found in honey, and polyols (e.g. sorbitol, mannitol) 
found in a variety of fruit and vegetables. Foods considered high in one or more FODMAPs are 
restricted for a short period of restriction period (4-6 weeks) (6). After this period, individuals are 
recommended to systematically reintroduce FODMAPs into their diet to determine the tolerable 
limits of intake. This aims to increase dietary diversity and the prebiotic content of the diet whilst 
maintaining symptom control (7). 
 
The low FODMAP diet requires alteration of intake of a number of food groups including grains, 
fruits and vegetables, and dairy products. There is therefore a potential risk of reduced intake of 
certain nutrients if suitable replacements are not included. Specifically, restricted foods such as 
wheat products are an important source of carbohydrate, fibre, B vitamins and iron (from fortified 
breakfast cereals); pulses provide protein and fibre; milk provides calcium and fat-soluble vitamins; 
and fruit and vegetable provide a wide range of vitamins, minerals and fibre. A reduction in overall 
food intake could also lead to decreased energy intake resulting in bodyweight loss. 
 
Three recent RCTs have examined the effect of a short-term low FODMAP diet on energy intake in 
IBS (Table 1). In one of the largest RCTs of the low FODMAP diet to date, energy intake was not 
different to those following placebo dietary advice and change in bodyweight was minimal (mean 
<0.5 kg) and not different between groups. (8). This contrasts with findings of two other large 4-
week RCTs, where within-group reductions in energy intake were demonstrated in the low FODMAP 
group (9, 10). However, in these trials the patients in the control groups also reduced their energy 
intake whilst following standard dietary advice, suggesting this may not be unique to the low 
FODMAP diet, but a result of following any therapeutic diet for IBS. Bodyweight was not reported in 
either study. 
 The low FODMAP diet does not lead to significant changes in protein and fat intake, however a 
number of studies have reported reductions in fibre intake during the low FODMAP diet.For 
example, one RCT in IBS (11), a small uncontrolled trial in patients with radiation-induced GI 
symptoms (12) reported reductions in fibre intake during the low FODMAP diet compared with 
baseline, whereas a large randomised comparative trial reported reductions in fibre and 
carbohydrate intakes that were more substantial than that reported in the control group receiving 
standard dietary advice(9). Inadequate substitution of high FODMAP grains and fruit and vegetables 
with suitable low FODMAP/high fibre replacements could explain these findings. However, data 
from another large RCT suggests there is no difference in fibre or macronutrient intake in patients 
with IBS after a 4-week low FODMAP diet (8), and therefore it is unclear whether fibre intake is 
definitively at risk throughout a low FODMAP intervention.  
 
There is some data to suggest that intakes of iron, calcium and other micronutrients may be 
compromised during the low FODMAP diet. One RCT in IBS has reported a within-group reduction in 
iron intake after low FODMAP diet compared with baseline according to 7-day food records of 47 
patients, although no difference was found for the proportion meeting the dietary iron 
recommendation (8). Importantly, significantly fewer achieved the recommended calcium intakes 
during the low FODMAP diet compared with baseline. Similarly, a substantial reduction in calcium 
intake has been reported for 41 patients with IBS compared with their habitual diet at baseline (10). 
This was accompanied by a reduction in intake of other micronutrients including retinol, thiamin and 
riboflavin . Variability in the impacts of a low FODMAP diet could be due to true variation in the 
populations studied, differences in habitual diet in that population due to cultural, religious or socio-
economic determinants, local availability of alternative food choices or the depth, detail and delivery 
method of the dietary advice given by the dietitian. Interestingly, the only two long term studies 
investigating dietary intake during a modified FODMAP diet (FODMAP personalisation, with 
FODMAP reintroduction to ƉĂƚŝĞŶƚƐ ?tolerance), suggest calcium (11, 13)*, iron and other 
micronutrients (13)* are not compromised at 6-18 months in patients with IBS.  
 
In addition to the impact on nutrient intake, the low FODMAP diet may have psychosocial impacts 
relating to nutrition. Patients have been reporteĚƚŽĨŝŶĚƚŚĞĚŝĞƚ ‘ĚĞŵĂŶĚŝŶŐƚŽĨŽůůŽǁ ?(12), and a 
questionnaire study reports eating out and travelling to be more difficult in those following a long 
term modified FODMAP diet compared with those following their usual diet (13)*. On the other 
hand, there are demonstrated beneficial effects of the low FODMAP diet on health-related quality of 
life (11, 14)*, and a range of food-related quality of life scores are no different to those following a 
habitual diet (13)*. Whether there are psychological ramifications in select patients as a result of 
following a long term modified FODMAP diet requires formal evaluation.  
 
Gluten-free diet  
A gluten-free diet (GFD) is the only established treatment for coeliac disease, which has been used 
since the 1950s to improve symptoms and intestinal mucosal healing (15). As the spectrum of 
gluten-related disorders has evolved and interest in using a GFD in IBS has emerged, there has been 
an increase in the numbers of people following this diet (16). This change is not confined to clinical 
practice, with increasing numbers of healthy people ŐŽŝŶŐ  ?ŐůƵƚĞŶ ĨƌĞĞ ? ĨŽƌ ƉĞƌĐĞŝǀĞĚ ŚĞĂůƚŚ
benefits (16). Although evidence consistently supports the role of a GFD in improving health in 
coeliac disease, dermatitis herpetiformis and gluten ataxia, the advantages of strict GFD adherence 
in other conditions or for lifestyle choices remains uncertain and in some cases untested (17). 
 
Gluten describes a complex network of storage proteins found in grains such as wheat (gliadins and 
glutenins), rye (secalins) and barley (hordeins). It has a key role in determining rheological dough 
properties and baking qualities (18). Adherence to a GFD entails three components: 1) the avoidance 
of foods containing gluten, 2) eating naturally occurring GF foods and 3) using commercially 
prepared gluten-free substitute foods (17). The labelling of gluten-free foods is defined in law in 
Europe and North America, with food mandated to contain less than 20 ppm gluten (20 mg 
gluten/kg food). Although foods are not completely GF, previous research has shown that this 
defined threshold is safe and tolerated in coeliac disease. This threshold is not universally adopted, 
with the Food Standards Australia New Zealand defining GF as <5 ppm gluten.  
 
Historically, concerns have been raised regarding the safety of oats in coeliac disease, leading to 
variations in international guidelines. This issue has recently been addressed in a systematic review 
and meta-analysis of 433 studies (19)**. Findings support the safety of pure (uncontaminated) oats 
in coeliac disease, with no evidence that oats influences symptoms, histology, immunity, or 
serological markers. 
 
As the use of the GFD grows and the number of available gluten-free foods rise, there has been 
increasing interest in the potential risks associated with a GFD. These risks relate to the inherent 
restrictive nature of the diet, the chemical modification of gluten-free foods as well as suboptimal 
dietary habits in those with coeliac disease (e.g. increased biscuit and cracker consumption (21)).  
 
In a recent review of 281 articles evaluating the nutritional quality of a GFD, findings showed fibre 
intake was low in individuals following a GFD, alongside sub-optimal intakes of vitamins B12 and D , 
folate, iron, zinc, magnesium and calcium (20)*. Calcium and vitamin D are micronutrients that may 
warrant close monitoring in individuals following a GFD. Both micronutrients can be deficient at the 
time of CD diagnosis, with recent studies demonstrating deficiencies persisting during follow-up 
despite adherence to the GFD (22, 23). Heavy metal bioaccumulation may also be a consequence of 
a GFD, with higher urine levels of total arsenic and blood levels of mercury, lead, and cadmium seen 
in individuals avoiding gluten (24)*. These novel findings necessitate further exploration to 
determine what influence this has long-term health outcomes.  
 The role a GFD has on macronutrient intake is conflicting in the literature. A number of studies have 
shown lower carbohydrate consumption in favour of a higher fat and protein intake in people 
following a GFD, whilst other observational studies contradict this (16). A common finding to all 
studies is that the GFD is high in sugar and low in fibre. This may have implications for glycaemic 
control, as has been shown in a recent study showing higher postprandial glycaemia for gluten-free 
pasta compared with conventional wheat pasta in healthy individuals (25)*. Coronary heart disease 
risk may also be affected, with a recent cohort study examining more than 110,000 people showing 
risk to be highest in those with the lowest gluten consumption, with this risk attributed to a lower 
intake of wholegrains (26)*.    
 
As understanding about GFDs evolve it is important to consider the psychosocial aspects associated 
with this diet. Previous research has shown that maintaining a GFD has cost implications, influences 
quality of life and can be socially isolating by restricting meals out (17, 27). Further work is now 
needed to address the long-term nutritional consequences of a GFD in individuals without coeliac 
disease, and determining whether gluten is really the culprit causal agent driving symptoms in these 
individuals.  
 
Other dietary interventions in gastrointestinal disorders 
Lactose restriction 
Lactose intolerance is characterised by GI symptoms associated with lactose ingestion. The disorder 
is associated with the LCT-139103C>T gene variant, which has variable prevalence but is highly 
prevalent in Asian populations. Treatment with lactose restriction involves reduced intake of high 
lactose dairy foods, including milk, yoghurt and soft cheese and substitution with low lactose or 
lactose-free alternative plant-based products (e.g. soy, rice, nut-based), although this has variable 
efficacy. Concerns regarding exclusion of this entire food group centre around the adequacy of 
protein, calcium and vitamin D intakes, although the nutritional adequacy of lactose restriction has 
not recently been explored. One study reported individuals with the LCT-13910c>T genotype 
consume a lower intake of dairy and have a lower plasma 25 (OH)D concentration (28), suggesting 
nutrient intake may be compromised  in some individuals with lactose intolerance, although the 
limitation of a cross-sectional design in this context is acknowledged. Short- and long-term 
evaluation of nutrient intake in patients with confirmed lactose intolerance (lactose restriction with 
subsequent symptom improvement) is required. 
 
High-fibre diet 
Dietary fibre manipulation is a common approach to managing some GI disorders, mostly through 
increasing intakes of high-fibre foods or the use of fibre supplements (e.g. psyllium). Rich sources of 
fibre include whole grain cereals and some fruits and vegetables and therefore a high-fibre diet is 
often associated with healthful properties. However, a high-fibre diet may have potentially 
deleterious effects on nutrient intake and status. Firstly, many trials have shown that some dietary 
fibres, including gel-forming and fermentable fibres, increase satiety and reduce energy intake (29). 
Secondly, in vitro studies have shown that fibres such as cellulose and hemi-cellulose can bind 
calcium, iron and zinc and therefore interfere with mineral absorption, although in vivo studies show 
conflicting evidence (30). Taken together, this suggests that where a high-fibre diet is required in 
populations at risk of undernutrition and mineral deficiencies, these patients should be carefully 
monitored by a dietitian. 
 
Despite the theoretical risk of deleterious effects, few studies investigating a high-fibre diet in GI 
disorders measure the consequential impact on nutrient intake. For example, a recent systematic 
review of 19 trials in diverticular disease described many studies where fibre led to beneficial effects 
in reducing or preventing symptoms of diverticulitis. The quality of studies was low, however, with 
few included studies measuring compliance with the intervention or dietary intake, and many 
lacking randomization or suitable control groups (31). Furthermore, a recent meta-analysis of seven 
RCTs reported that fibre supplementation in chronic constipation increased response, increased 
stool frequency and softened stool consistency compared with placebo (32)*. However, again few of 
the trials reported the impact of fibre supplementation on background dietary fibre intake, let alone 
nutrient intake, diet quality or nutritional status.  
 
The most recent major fibre intervention study in GI disorders was a RCT of both high-fibre diet and 
low-fibre diet, compared with habitual-fibre diet, in the prevention of acute and chronic GI toxicity in 
166 patients receiving pelvic radiotherapy for lower GI or gynaecological cancer (33)*. This trial 
reported a smaller reduction in toxicity score in the high-fibre group both at the end of radiotherapy 
and 1-year following radiotherapy compared with the habitual-fibre group. Following detailed 
dietary counselling from a dietitian, fibre and protein intake was higher in the high-fibre diet group 
but with no significant impact on energy, fat and carbohydrate intake (33)*. 
 
Specific-carbohydrate diet 
The specific carbohydrate diet excludes all grains (e.g. wheat, barley, corn, rice), sugars (except for 
honey), processed foods and milk. The diet is gaining some traction for its use in inflammatory bowel 
disease (IBD), where a survey of patients showed great interest in the diet with some self-reported 
benefit (34). However, the SCD has not been subjected to a RCT in IBD and only data from case-
series exist in the literature. For example, a retrospective review of 26 children who followed the 
SCD reported a reduction in disease score at four weeks and six months (35). Meanwhile the same 
centre reported GI symptom improvement in seven children following a modified SCD (allowing rice, 
oats, quinoa) but failed to show complete mucosal healing in any (36). However, a dietary analysis of 
eight children following the SCD reported adequate energy intakes in approximately two thirds of 
patients and achievement of vitamin requirements in the majority (37)*. Intakes of calcium were low 
but were consistent with population norms.    
 
Conclusion  
The use of diet as a therapeutic intervention in GI disorders has been driven by growing evidence of 
clinical efficacy but also patient interest in use of diet as an alternative to drug therapy. 
Unfortunately a shortcoming of diet therapy in this context is the potential and established effects 
on nutrient intake and/or status. This, as well as the potential impact on psychosocial aspects, 
should be carefully weighed against the likely benefit of dietary intervention in each clinical case. 
Whether individuals with GI disorders that self-modify their diet rather than seek expert guidance 
from a dietitian face a significantly greater risk to nutritional adequacy is unknown. In order to clarify 
the long term impact of dietary interventions in GI disorders, future trials that carefully measure 
longitudinal dietary intake are necessary. 
 
Key points: Please include 3 to 5 key bullet points that summarise your article after the main body of 
text. The aim of these is to encourage others to cite your article based on the stated key points. 
Please ensure each bullet is no longer than one sentence. 
x A short term low FODMAP diet has specific impacts on nutrient intake, however prospective 
follow up studies are required to confirm whether this continues in the long term 
x The use of a GFD beyond coeliac disease needs to be made judiciously, as nutritional 
consequences are increasingly recognised, including reduced fibre intake and heavy metal 
bioaccumulation.   
x A high fibre diet may be effective in diverticular disease and constipation but careful 
monitoring of the impact on energy intake and micronutrient status is required. 
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